None

Dako, Panagene sign supply agreement for PNA oligomer component

Panagene announced it has signed a supply agreement with Dako Denmark A/S to supply PNA oligomer key component for incorporation into Dako's diagnostic or research products. Dako, an Agilent Technolog...

Dako Denmark A/S: Dako enters collaboration with Eli Lilly and Company for development of companion diagnostics

GLOSTRUP, Denmark, Jan. 7, 2013 - Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Eli Lilly and Company for the development of companio...

Dako collaborates with Eli Lilly for companion diagnostics

Dako has entered into a master framework agreement with Eli Lilly and Company for the development of companion diagnostic tests to identify patients who may be more likely to benefit from an investiga...

Dako's companion diagnostics for Perjeta wins FDA OK

The FDA has granted Dako approval to market its HercepTest and HER2 FISH pharmDx as companion diagnostics for newly approved  -More- 

Dako strikes supply deal with S. Korean biotech firm

Panagene, a South Korean company, has agreed to supply Dako with its peptide nucleic acid probes for undisclosed terms.  -More- 

Dako Enters Collaboration With Lilly For Development Of Companion Diagnostics

SANTA CLARA (dpa-AFX) - Dako, an Agilent Technologies Inc. (A) company, announced Monday that it has entered into a master framework agreement with Eli Lilly and Co. (LLY) for the development of c...

Dako, Pfizer team up for companion diagnostics

Denmark-based cancer diagnostics solutions manufacturer Dako announced that it has entered into collaboration agreement with Pfizer in the field of companion diagnostics.

FDA Approves Two Dako Assays as Companion Diagnostics for Genentech's New Breast Cancer Medicine Kadcyla

GLOSTRUP, DENMARK -- (Marketwire) -- 03/05/13 -- Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, announced today it has received approval from the U.S. Food and Dr...

Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes.

The HER2 amplicon on chromosome 17q is variable in size and occasionally includes Topoisomerase 2A (TOP2A) at 17q21-22. It has been suggested that TOP2 co-amplification, not HER2 amplification on chro...

An Immunohistochemical and Fluorescence in Situ Hybridization-based Comparison Between the Oracle HER2 Bond Immunohistochemical System, Dako HercepTest, and Vysis PathVysion HER2 FISH Using Both Commercially Validated and Modified ASCO/CAP and United King

Immunohistochemistry (IHC) is used as the frontline assay to determine HER2 status in invasive breast cancer patients. The aim of the study was to compare the performance of the Leica Oracle HER2 Bond...

Platelet expression of CD62P in hypotrophic newborns.

Background: Hypotrophic newborns demonstrate a reduced blood platelet count and therefore may have haemostasis disorders. The antigen density of CD62P on the surface of platelets may indicate the acti...

The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma.

The aim of the study was to establish the prognostic and predictive value of Bax and Bcl-2 proteins in conjunction with the host immune response in primary epithelial ovarian carcinoma.83 patients wer...

Fibroadenoma of the vulva-simultaneous with breast fibroadenomas and uterine myoma.

PURPOSE.: To present a rare case of multiple fibroadenomas in breast and vulva and myomas in the uterus. In addition, to show the usefulness of receptor detection as a basis for the indication of anti...